M. Kulyk & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.23M | Buy |
74,253
+1,384
| +2% | +$153K | 1.79% | 16 |
|
|
2025
Q1 | $8.17M | Sell |
72,869
-15,797
| -18% | -$1.77M | 1.87% | 17 |
|
|
2024
Q4 | $8.19M | Sell |
88,666
-11,801
| -12% | -$1.09M | 1.77% | 17 |
|
|
2024
Q3 | $8.42M | Sell |
100,467
-3,412
| -3% | -$286K | 1.69% | 17 |
|
|
2024
Q2 | $7.13M | Buy |
103,879
+14,651
| +16% | +$1.01M | 1.66% | 20 |
|
|
2024
Q1 | $6.54M | Buy |
89,228
+5,795
| +7% | +$424K | 1.52% | 23 |
|
|
2023
Q4 | $6.76M | Sell |
83,433
-919
| -1% | -$74.4K | 1.57% | 22 |
|
|
2023
Q3 | $6.32M | Buy |
84,352
+1,337
| +2% | +$100K | 1.76% | 14 |
|
|
2023
Q2 | $6.4M | Sell |
83,015
-5,855
| -7% | -$451K | 1.79% | 15 |
|
|
2023
Q1 | $7.37M | Buy |
88,870
+1,021
| +1% | +$84.7K | 2.23% | 12 |
|
|
2022
Q4 | $7.54M | Sell |
87,849
-193
| -0.2% | -$16.6K | 2.52% | 9 |
|
|
2022
Q3 | $5.43M | Buy |
88,042
+1,572
| +2% | +$97K | 1.89% | 13 |
|
|
2022
Q2 | $5.35M | Buy |
86,470
+3,275
| +4% | +$202K | 1.66% | 17 |
|
|
2022
Q1 | $4.95M | Sell |
83,195
-19,076
| -19% | -$1.13M | 1.35% | 29 |
|
|
2021
Q4 | $7.43M | Buy |
102,271
+5,329
| +5% | +$387K | 1.92% | 14 |
|
|
2021
Q3 | $6.77M | Buy |
96,942
+4,741
| +5% | +$331K | 2.17% | 10 |
|
|
2021
Q2 | $6.35M | Buy |
92,201
+9,122
| +11% | +$628K | 2.29% | 9 |
|
|
2021
Q1 | $5.37M | Buy |
83,079
+28,219
| +51% | +$1.82M | 2% | 11 |
|
|
2020
Q4 | $3.2M | Buy |
+54,860
| New | +$3.2M | 1.77% | 25 |
|